View in EDS HTML Full Text PDF Full Text

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Authors: Lee JV; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Housley F; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Yau C; Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.; Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA., Nakagawa R; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Winkler J; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Anttila JM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland., Munne PM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland., Savelius M; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland., Houlahan KE; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Van de Mark D; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Hemmati G; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Hernandez GA; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Zhang Y; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Samson S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Breast Science Advocacy Core, UCSF Breast Oncology Program, San Francisco, California, USA., Baas C; Alamo Breast Cancer Foundation, San Antonio, Texas, USA., Kok M; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Esserman LJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Department of Surgery, University of California, San Francisco, California, USA.; Department of Radiology, University of California, San Francisco, California, USA., van 't Veer LJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA., Rugo HS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA., Curtis C; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA., Klefström J; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland., Matloubian M; Department of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, California, USA. mehrdad.matloubian@ucsf.edu., Goga A; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
Source: Nature communications [Nat Commun] 2022 Nov 21; Vol. 13 (1), pp. 7140. Date of Electronic Publication: 2022 Nov 21.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36414627
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+JV%22">Lee JV</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Housley+F%22">Housley F</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.; Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Nakagawa+R%22">Nakagawa R</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Winkler+J%22">Winkler J</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Anttila+JM%22">Anttila JM</searchLink>; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Munne+PM%22">Munne PM</searchLink>; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Savelius+M%22">Savelius M</searchLink>; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Houlahan+KE%22">Houlahan KE</searchLink>; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Van+de+Mark+D%22">Van de Mark D</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Hemmati+G%22">Hemmati G</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Hernandez+GA%22">Hernandez GA</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Samson+S%22">Samson S</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Breast Science Advocacy Core, UCSF Breast Oncology Program, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Baas+C%22">Baas C</searchLink>; Alamo Breast Cancer Foundation, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kok+M%22">Kok M</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Department of Surgery, University of California, San Francisco, California, USA.; Department of Radiology, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+LJ%22">van 't Veer LJ</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Curtis+C%22">Curtis C</searchLink>; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Klefström+J%22">Klefström J</searchLink>; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Matloubian+M%22">Matloubian M</searchLink>; Department of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, California, USA. mehrdad.matloubian@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Goga+A%22">Goga A</searchLink>; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Nov 21; Vol. 13 (1), pp. 7140. <i>Date of Electronic Publication: </i>2022 Nov 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36414627
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-022-34570-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7140
    Titles:
      – TitleFull: Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee JV
      – PersonEntity:
          Name:
            NameFull: Housley F
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Nakagawa R
      – PersonEntity:
          Name:
            NameFull: Winkler J
      – PersonEntity:
          Name:
            NameFull: Anttila JM
      – PersonEntity:
          Name:
            NameFull: Munne PM
      – PersonEntity:
          Name:
            NameFull: Savelius M
      – PersonEntity:
          Name:
            NameFull: Houlahan KE
      – PersonEntity:
          Name:
            NameFull: Van de Mark D
      – PersonEntity:
          Name:
            NameFull: Hemmati G
      – PersonEntity:
          Name:
            NameFull: Hernandez GA
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Samson S
      – PersonEntity:
          Name:
            NameFull: Baas C
      – PersonEntity:
          Name:
            NameFull: Kok M
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
      – PersonEntity:
          Name:
            NameFull: van 't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Curtis C
      – PersonEntity:
          Name:
            NameFull: Klefström J
      – PersonEntity:
          Name:
            NameFull: Matloubian M
      – PersonEntity:
          Name:
            NameFull: Goga A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 11
              Text: 2022 Nov 21
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1